NCT02064179View on ClinicalTrials.gov

Assessment of the Efficacy of the First Aspirin Dose in Children Undergoing Surgery for Congenital Heart Disease (CHD) Who Require Post-operative Antiplatelet Therapy

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Congenital Heart Disease
All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02064179 - Assessment of the Efficacy of the First Aspirin Dose in Children Undergoing Surgery for Congenital Heart Disease (CHD) Who Require Post-operative Antiplatelet Therapy | Biotech Hunter | Biotech Hunter